Basics |
Avanos Medical, Inc.
|
IPO Date: |
October 20, 2014 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$570.19M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.51 | 1.59%
|
Avg Daily Range (30 D): |
$0.25 | 1.92%
|
Avg Daily Range (90 D): |
$0.23 | 1.59%
|
Institutional Daily Volume |
Avg Daily Volume: |
.25M |
Avg Daily Volume (30 D): |
.38M |
Avg Daily Volume (90 D): |
.4M |
Trade Size |
Avg Trade Size (Sh.): |
63 |
Avg Trade Size (Sh.) (30 D): |
56 |
Avg Trade Size (Sh.) (90 D): |
59 |
Institutional Trades |
Total Inst.Trades: |
2,534 |
Avg Inst. Trade: |
$1.57M |
Avg Inst. Trade (30 D): |
$1.26M |
Avg Inst. Trade (90 D): |
$1.39M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.57M |
Avg Closing Trade (30 D): |
$1.25M |
Avg Closing Trade (90 D): |
$1.41M |
Avg Closing Volume: |
51.98K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-8.36
|
$.14
|
$-8.64
|
Diluted EPS
|
$-8.37
|
$.14
|
$-8.64
|
Revenue
|
$ 689.2M
|
$ 167.5M
|
$ 179.6M
|
Gross Profit
|
$ 376.3M
|
$ 89.8M
|
$ 98M
|
Net Income / Loss
|
$ -384.6M
|
$ 6.6M
|
$ -397.3M
|
Operating Income / Loss
|
$ -389.9M
|
$ 10.3M
|
$ -418.5M
|
Cost of Revenue
|
$ 312.9M
|
$ 77.7M
|
$ 81.6M
|
Net Cash Flow
|
$ 21.2M
|
$ -10.7M
|
$ 18.7M
|
PE Ratio
|
|
|
|
Splits |
May 15, 2006:
100:1
|
|